F-18 PSMA Uptake in Male Breast Cancer during Restaging Evaluation of Carcinoma Prostate

Fluorine-18 prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography scan is widely used for restaging of prostate cancer. We present a case where false-positive PSMA uptake was seen in metachronous carcinoma breast during restaging workup of carcinoma prostate.

Detalles Bibliográficos
Autores principales: Zade, Anand, Shetty, Shishir, Ambekar, Asawari, Karpe, Makarand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Interesting Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855249/
https://www.ncbi.nlm.nih.gov/pubmed/36686311
http://dx.doi.org/10.4103/ijnm.ijnm_127_21
_version_ 1784873333446148096
author Zade, Anand
Shetty, Shishir
Ambekar, Asawari
Karpe, Makarand
author_facet Zade, Anand
Shetty, Shishir
Ambekar, Asawari
Karpe, Makarand
author_sort Zade, Anand
collection PubMed
description Fluorine-18 prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography scan is widely used for restaging of prostate cancer. We present a case where false-positive PSMA uptake was seen in metachronous carcinoma breast during restaging workup of carcinoma prostate.
format Online
Article
Text
id pubmed-9855249
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-98552492023-01-21 F-18 PSMA Uptake in Male Breast Cancer during Restaging Evaluation of Carcinoma Prostate Zade, Anand Shetty, Shishir Ambekar, Asawari Karpe, Makarand Indian J Nucl Med Interesting Image Fluorine-18 prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography scan is widely used for restaging of prostate cancer. We present a case where false-positive PSMA uptake was seen in metachronous carcinoma breast during restaging workup of carcinoma prostate. Wolters Kluwer - Medknow 2022 2022-11-02 /pmc/articles/PMC9855249/ /pubmed/36686311 http://dx.doi.org/10.4103/ijnm.ijnm_127_21 Text en Copyright: © 2022 Indian Journal of Nuclear Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Interesting Image
Zade, Anand
Shetty, Shishir
Ambekar, Asawari
Karpe, Makarand
F-18 PSMA Uptake in Male Breast Cancer during Restaging Evaluation of Carcinoma Prostate
title F-18 PSMA Uptake in Male Breast Cancer during Restaging Evaluation of Carcinoma Prostate
title_full F-18 PSMA Uptake in Male Breast Cancer during Restaging Evaluation of Carcinoma Prostate
title_fullStr F-18 PSMA Uptake in Male Breast Cancer during Restaging Evaluation of Carcinoma Prostate
title_full_unstemmed F-18 PSMA Uptake in Male Breast Cancer during Restaging Evaluation of Carcinoma Prostate
title_short F-18 PSMA Uptake in Male Breast Cancer during Restaging Evaluation of Carcinoma Prostate
title_sort f-18 psma uptake in male breast cancer during restaging evaluation of carcinoma prostate
topic Interesting Image
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855249/
https://www.ncbi.nlm.nih.gov/pubmed/36686311
http://dx.doi.org/10.4103/ijnm.ijnm_127_21
work_keys_str_mv AT zadeanand f18psmauptakeinmalebreastcancerduringrestagingevaluationofcarcinomaprostate
AT shettyshishir f18psmauptakeinmalebreastcancerduringrestagingevaluationofcarcinomaprostate
AT ambekarasawari f18psmauptakeinmalebreastcancerduringrestagingevaluationofcarcinomaprostate
AT karpemakarand f18psmauptakeinmalebreastcancerduringrestagingevaluationofcarcinomaprostate

Ejemplares similares